Project Butterfield
Project Butterfield possesses the patents and prototype for a novel, device-based application for the treatment of HCV. The Company had inconclusive clinical mechanisms despite treatment experience with 50+ patients. They were seeking a strategic, organizational, and financial framework to pursue a pivotal PMA trial in the US. Healthios designed and executed their comprehensive development strategy, engaged with select financial and strategic investors, and sharpened clinical/regulatory strategy to ensure more direct pathways to FDA approval. We initiated the cornerstone relationships aimed at streamlining new product development, broadening the Company's patent estate, and fortifying competitive advantage. Healthios generated a series of financing proposals, including an offer from a global strategic party of a $100 million+ acquisition predicated upon the success of milestones. We than completed a new product design, recruited a top-tier Medical Advisory Board, and fullfilled enrollment of the clinical trial.